Patient Education & Public Health

Scattered, Siloed, and Lost: The Case for a Portable TB Screening Record Every American Can Own

Millions of Americans have undergone tuberculosis screening at some point in their lives, yet those results exist in disconnected systems that neither patients nor providers can reliably access. Without a portable, patient-controlled TB screening history, the American healthcare system continues to repeat tests unnecessarily while simultaneously missing critical gaps in protection. The solution may already exist in models developed abroad — if the US can find the will to adopt them.

Sep 14, 2026

Expecting the Unexpected: How Tuberculosis Hides in Plain Sight During Pregnancy and the First Year of Life

Tuberculosis poses a profound but frequently unrecognized threat to pregnant women and their newborns across the United States, yet obstetric training rarely equips providers to identify it. From vertical transmission risks to the diagnostic challenges of TB disease during pregnancy, the gaps in maternal health protocols are leaving two of the most vulnerable populations unprotected. Integrating TB awareness into standard prenatal and postnatal care is no longer optional — it is a public health

Aug 31, 2026

Small Patients, Overlooked Diagnoses: Closing the Tuberculosis Detection Gap in American Pediatric Care

Childhood tuberculosis in the United States is frequently missed or delayed due to nonspecific symptoms, limited clinician experience, and inconsistent screening protocols in pediatric settings. The consequences extend beyond individual patients, creating silent reservoirs of infection within families and communities. This article examines the diagnostic challenges unique to children and outlines evidence-based steps pediatricians can take to improve early detection.

Aug 30, 2026

Neighbors as Healers: The Quiet Power of Community Health Workers in America's Fight Against Tuberculosis

Across underserved American neighborhoods, a growing corps of community health workers is achieving what clinic-based medicine often cannot: reaching TB patients where they live, speaking their language, and guiding them through the full arc of treatment. Yet chronic underfunding and a persistent lack of professional recognition threaten to dismantle one of public health's most effective tools in the effort to end tuberculosis in the United States.

Aug 29, 2026

Rewriting the Story of TB: Why Dismantling Stigma Is as Urgent as Developing New Drugs

Tuberculosis in America carries a cultural weight far heavier than its clinical profile alone would warrant — a legacy of shame, poverty, and social exclusion that continues to delay diagnosis and discourage treatment-seeking decades after effective therapies became widely available. Shifting public perception of TB from a mark of moral failure to a treatable medical condition is not a secondary concern for public health advocates; it is a prerequisite for ending the epidemic. This piece examine

Aug 28, 2026

Locked In, Packed In, Left Exposed: The Congregate Settings Quietly Fueling Tuberculosis Transmission Across America

Prisons, homeless shelters, nursing homes, and food processing facilities share more than crowded conditions—they share a dangerous vulnerability to tuberculosis outbreaks that public health systems have been slow to address. Despite documented transmission chains in these environments, infection control standards remain inconsistently enforced and surveillance gaps persist. Understanding how TB moves through congregate settings is essential for any community serious about protecting its most ex

Aug 28, 2026

A New Arsenal Against an Ancient Enemy: The Scientists Reimagining Tuberculosis Treatment

The standard tuberculosis drug regimen has remained largely unchanged for more than half a century — a grueling, months-long course of medications that strains patient compliance and falls short against drug-resistant strains. A new generation of researchers is working to change that, advancing experimental compounds and novel treatment combinations through clinical trials that could fundamentally transform how TB is managed in the United States and beyond. Here is where that science stands toda

Aug 28, 2026

When One Disease Is Not Enough: Confronting Tuberculosis in Patients Living with Diabetes, HIV, and Addiction

For many Americans living with tuberculosis, the disease does not arrive alone. The intersection of TB with chronic conditions such as diabetes, HIV infection, and substance use disorder creates a cascade of clinical and social complications that standard TB care models are ill-equipped to address. Understanding how these overlapping conditions interact—and how integrated care can change outcomes—is essential for both medical professionals and the communities they serve.

Aug 27, 2026

Carrying TB Without Knowing It: Understanding Latent Infection and Why Treatment Cannot Wait

An estimated 5 to 10 million Americans are living with latent tuberculosis infection—a dormant form of the disease that produces no symptoms but carries a lifelong risk of progressing to active, contagious TB. Understanding who is at risk, when to seek testing, and what modern treatment options are available is essential knowledge for patients, caregivers, and clinicians alike. This guide provides a comprehensive overview of latent TB: what it is, why it matters, and how early intervention can p

Aug 27, 2026